Cargando…
Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo
Chemotherapy resistant high grade serous ovarian cancer remains a clinically intractable disease with a high rate of mortality. We tested a novel glycosylated antitumor ether lipid called l-Rham to assess the in vitro and in vivo efficacy on high grade serous ovarian cancer cell lines and patient sa...
Autores principales: | Nachtigal, Mark W, Musaphir, Paris, Dhiman, Shiv, Altman, Alon D, Schweizer, Frank, Arthur, Gilbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379490/ https://www.ncbi.nlm.nih.gov/pubmed/34416424 http://dx.doi.org/10.1016/j.tranon.2021.101203 |
Ejemplares similares
-
The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer
por: Nachtigal, Mark W., et al.
Publicado: (2022) -
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019
por: Winchar, Kelcey, et al.
Publicado: (2022) -
Syntheses of l-Rhamnose-Linked Amino Glycerolipids and Their Cytotoxic Activities against Human Cancer Cells
por: Ogunsina, Makanjuola, et al.
Publicado: (2020) -
Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models
por: Heredia-Soto, Victoria, et al.
Publicado: (2022) -
Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin
por: Raizman, Zachary, et al.
Publicado: (2017)